Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

Anaphylaxis Canada Launches New Strategy To Help Keep More Than 250,000 Children And Young Adults With Severe Food Allergies Safe
Anaphylaxis Canada is responding to the growing public health challenge of keeping teens and young adults with potentially life-threatening food allergies safe by creating a number of interactive tools including a groundbreaking new website, http://www.whyriskit.ca, an online "Reaction Registry" and radio podcasts. These tools are part of a comprehensive new strategy to help allergic youth manage risky situations by reaching out to them in forums in which they are comfortable.
generic viagra online
Vertos Medical's Mild(R) Procedure Gets Nod From Leading Pain Medicine Physicians
Leading interventional pain physicians from key U.S. centers gathered at a special clinical symposium to share their experience with Vertos Medical"s mild (Minimally Invasive Lumbar Decompression), the least invasive surgical procedure for treating lumbar spinal stenosis (LSS), with no implants left behind.* Their early clinical experiences suggest that mild may be an appropriate treatment alternative earlier in the LSS progression, as mild patients have shown favorable results when comparing post-treatment improvement at three months to open surgical procedure patient results at one year1. Moreover, mild leaves future surgical options open. Purchase zoloft to treat depression.
News of the day
Hypoglycemia Increases Mortality Risk, Lengthens Hospital Stay For Diabetes Patients -- Even Outside The ICU
Diabetes patients who are hospitalized for non-critical illnesses, and develop hypoglycemia while hospitalized, are likely to remain hospitalized longer and face greater risk of mortality both during and after hospitalization, according to a study published in the July issue of Diabetes Care.
Mental Health

Hyperferritinemia Is Another Surrogate Marker Of Advanced Liver Disease

High serum ferritin, being a hallmark of hereditary hemochromatosis , is frequently found in chronic hepatitis C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty liver disease patients . A study in Italy has investigated the link between ferritin and steatosis in a non-obese cohort of non-alcoholic patients. In southern European populations, high ferritin levels, after exclusion of diagnosis of HH, represent a risk factor for steatosis and clinical relevance, being associated with low platelet count. Patients with chronic hepatitis C virus (HCV) infection often have elevated serum iron indices, but these do not accurately reflect hepatic iron content, nor are they able to predict clinically important endpoints, such as progression of fibrosis and responsiveness to interferon-based regimens. Studies that attempt to link iron and the course of chronic hepatitis C have been inconclusive. In chronic hepatitis C, steatosis is a common histological finding, occurring in 30%-70% of such patients. The biological mechanism underlying steatosis in HCV infection is not definitively understood, and is considered to be multifactorial with metabolic mechanisms, including insulin resistance and iron overload. A research article published on May 7, 2009 in the World Journal of Gastroenterology addresses this problem. The research team led by Professor Licata from Gastroenterology and Hepatology Unit of Palermo University analyzed in a cross-sectional study, a cohort of non-obese, non-alcoholic patients with compensated chronic liver disease characterized by elevated serum ferritin levels, of varying etiology, excluding hemochromatosis, to reassess the link between hyperferritinemia and other markers of the metabolic syndrome, mainly steatosis. All data provide further evidence that hyperferritinemia might be another surrogate marker of advanced liver disease of any etiology. Reference: Licata A, Nebbia ME, Cabibbo G, Lo Iacono G, Barbaria F, Brucato V, Alessi N, Porrovecchio S, Di Marco V, Craxç¬ A, Cammç  C. Hyperferritinemia is a risk factor for steatosis in chronic liver disease. World J Gastroenterol 2009; 15(17): 2132-2138 http://www.wjgnet.com/1007-9327/15/2132.asp Correspondence to: Dr. Anna Licata, MD, Gastroenterology and Hepatology Unit, Department of Internal Medicine, University of Palermo, 90127 Palermo, Italy. Lin Tian World Journal of Gastroenterology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009